{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1070845763182203527.json","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402501928"}],"foaf:Person":[{"foaf:name":[{"@language":"en","@value":"Masui, Sho"}]}],"career":[{"institution":{"notation":[{"@language":"en","@value":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital･Graduate School of Pharmaceutical Sciences, Kyoto University"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1050845763182203520","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"HDL","@value":"http://hdl.handle.net/2433/241257"},{"@type":"DOI","@value":"10.1007/s11095-019-2624-5"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s11095-019-2624-5.pdf"},{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s11095-019-2624-5/fulltext.html"},{"@type":"PMID","@value":"30989405"},{"@type":"HANDLE","@value":"2433/241257"},{"@type":"NAID","@value":"120006624113"}],"notation":[{"@language":"en","@value":"Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin’s Lymphoma"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01221:0004030140_O2emf02ZxWkDaDL51hcqhBxQTqU"},{"@type":"CIA","@value":"120006624113_NBuBU6tMG49Zyy3PrOfBxrHA11Q"}]}